Care Home Development Finance

What is care home development finance?

Care home development finance funds the construction of a new care home or the extension of an existing one. The facility is short-term, typically 18 to 36 months, draws down against milestones certified by a monitoring surveyor, and exits once the home is registered with the regulator, admitting residents and building toward stabilised occupancy. Interest rolls up through the build.

FD Commercial arranges UK care home development finance from £250,000, with LTC up to 70% and LTGDV up to 65% where an experienced operator is committed to the scheme. The operator is the case. Everything else follows from it.

The demand backdrop is the strongest of any asset class we fund. According to Knight Frank's healthcare research, the UK needs in excess of 10,000 new care beds a year to keep pace with demand, and delivery has consistently run at less than half that, while a large share of existing stock fails modern standards and leaves the market each year. According to the ONS, the number of people aged 85 and over in the UK is projected to nearly double over the next 25 years. Undersupply on that scale is why lender appetite for well-structured care schemes has held up through every recent market wobble.

Run your scheme through our development finance calculator and developer profit calculator early. Care home appraisals fail on trading assumptions far more often than on build costs, and testing the gearing before you commit to the site is cheaper than discovering the problem at valuation.

How do lenders handle CQC registration timing?

The finance completes before the registration exists. A care home cannot be registered with the Care Quality Commission (or the Care Inspectorate in Scotland, or Care Inspectorate Wales) until the building is complete and inspectable, which means the development lender is funding an asset that is legally unable to trade until after practical completion. Every care home development facility is built around that fact.

Lenders bridge the registration gap by underwriting the operator rather than the registration: an operator with existing registered homes and a clean regulatory history, a registered manager identified early, and a registration application programmed so first admissions follow soon after practical completion. The registration risk never disappears, but with the right operator it becomes a timing item rather than a credit item.

The practical instruction we give every care client is to appoint the registered manager and start the registration groundwork months before practical completion, not after the keys are handed over. Registration involves provider and manager applications, interviews and a premises inspection, and a home standing finished but unregistered is burning rolled-up interest with no possibility of income. We see the gap between completion and first admission stretch past six months when registration is treated as an afterthought, and close to six weeks when it is programmed properly.

Why is the operator covenant the heart of the deal?

Because the building is worth very little without one. A care home's value is its trading, and its trading depends on the operator's ability to register the home, staff it, satisfy the regulator and fill the beds at sustainable fee rates. Lenders therefore put the operator through the same scrutiny a commercial lender puts a tenant covenant through: existing homes and their regulatory ratings, staff retention, fee mix, and management depth.

What we have found across the care schemes we place is that lenders will forgive an unglamorous location sooner than a thin operator. A developer with no care history can absolutely get funded, but only where an established operator is committed under a lease, a management agreement or a forward sale, and that commitment needs to be documented before submission, not promised during it. A first-time operator with no registered homes borrowing to build their first care home is the hardest structure in the sector, and we say that as brokers who have placed them: the route usually runs through buying a trading home first, which our first-time operator guide covers in detail.

One case that stays with us involved a well-funded developer with a consented 66-bed site in the South East and no operator attached, who assumed the operator could be found once the shell was up. Two years of enquiries later the scheme funded only after a regional group signed a 30-year lease, at which point three lenders competed for a deal none of them would previously touch. The building had not changed. The covenant had.

What are the beds economics lenders test?

Care home underwriting comes down to cost per bed against value per bed. On the cost side, new-build UK care homes typically run £120,000 to £180,000 per bed all-in depending on region and specification, with dementia-specialist and nursing provision at the upper end. Lenders test the figure against completed comparables, and a cost per bed well below the range signals an under-specified scheme rather than a bargain.

On the income side, the model is fee rate multiplied by occupancy, less staffing and operating costs, capitalised as a multiple of EBITDA. Weekly fees vary enormously: local-authority-funded residents in some regions pay under £900 a week while private-pay dementia care in the South East clears £1,800. The funding mix assumption matters as much as the headline rate, and an appraisal built on 90% private pay in a local-authority-dominated catchment will not survive the valuer. Staffing is the other pressure point; agency-heavy staffing models erode EBITDA quickly and lenders now ask about recruitment as a matter of course.

Fill rate completes the picture. A realistic ramp-up to stabilised occupancy runs two to three years for a new home. Appraisals that fill 60 beds in six months get repriced by every credit committee that sees them.

What planning and site factors do lenders check?

Care homes sit in use class C2, and lenders want the consent clean: full permission for the bed numbers in the appraisal, conditions understood, and no unresolved section 106 obligations hanging over the programme. Site geometry matters more than most developers expect. A 60 to 70 bed home wants something close to an acre once parking, service access, garden and outdoor space and single-storey or two-storey massing are accounted for, and a consented scheme that squeezes the beds onto too small a plot usually gives the space back through the specification, which the valuer then prices.

The other site test is the catchment, on both sides of the business. Resident demand is mapped against the over-75 population, the wealth profile that supports private fees, and the existing and consented competing beds within the local market. Staff supply is now checked with equal weight, because a home that cannot recruit runs on agency staffing and agency staffing erodes the EBITDA the whole valuation rests on. A beautifully designed home in a village with no staff catchment is a harder credit case than a plain one on the edge of a working town, and lenders have learned that the hard way over the last decade.

Walk the competition before you buy the site. Two afternoons visiting every home within twenty minutes tells you more about achievable fees and local staffing than any desktop report.

What LTC, LTGDV and pricing apply to care home development finance?

Indicative bands in 2026:

• Experienced operator borrowing to build, existing homes with good regulatory ratings: 65% to 70% LTC, 60% to 65% LTGDV.
• Developer-led scheme with an established operator committed under lease or forward sale: 60% to 70% LTC depending on the covenant strength.
• Extension to a registered, trading home: often the strongest terms in the sector, because the covenant and demand are proven.
• First-time entrant without an operator attached: 50% to 55% LTC where fundable at all, sponsor equity 40% or more.

Rates in 2026 sit broadly between 0.85% and 1.15% per month on specialist terms, or 7% to 11% per annum where priced as a margin over the Bank of England base rate, currently 3.75%. Arrangement fees run 1% to 2%, plus valuation, monitoring surveyor and legal costs. All figures are indicative and subject to lender assessment.

Active funders include Shawbrook, United Trust Bank and Hope Capital on the specialist development side, and Cambridge & Counties among the challenger banks backing experienced operators. Healthcare is a genuinely specialist lending market. The list of funders who understand care trading is shorter than the list who claim to, and placing the deal with a lender whose credit team has care homes on its book already is worth more than a quarter point on the rate.

Can I fund an extension to an existing care home?

Yes, and extensions are often the easiest care deals to place. Adding a 20-bed dementia wing to a registered, trading home means the operator covenant, the regulatory history and the local demand are all proven, and the incremental income from the new beds is straightforward to model. Lenders assess three extra things: the impact of construction on the existing residents and the home's day-to-day operation, the variation to the existing registration, and whether the existing home's staffing can stretch across the enlarged bed count.

Phasing matters operationally. A build programme that forces bed closures in the existing home eats the very income supporting the facility, so contractors with live-environment healthcare experience are worth their premium. Around a third of the care enquiries we take are extensions rather than new builds, and they typically fund at the strongest terms in the sector.

What exit strategies do lenders accept?

Two exits dominate. The first is refinance onto a long-term care home mortgage once the home is registered, trading and demonstrably filling beds; long-term lenders size against EBITDA and debt service cover, and most want to see occupancy well into its ramp-up before completing. The second is sale to an operator group or healthcare investor, which suits developer-led schemes where the operator was always going to be the long-term owner.

Most retained care schemes refinance 12 to 24 months after first admissions, once occupancy and fee income give a long-term lender a trading record to underwrite. Where the development facility term runs out before the trading record is ready, a development exit facility bridges the gap at a lower rate than extending the development loan. Our guides on care home finance rates and costs and how CQC ratings affect care home mortgages cover the refinance side in detail, including why a first inspection rating shapes the terms available.

Worked example: funding a 62-bed new-build care home

How we arrange your care home development facility

Frequently asked questions